the aid library

LIST OPTIONS

Filter

9906

Sort by:

Direction:

Download (354)

View PDF (644)

Patient Decontamination Recommendations for Hospitals

Emergency Medical Services Authority (EMSA) California (2005) C2

"This document provides recommendations for protecting healthcare providers and managing patients in the event of a hazardous materials exposure. Content was compiled through nationally recognized, current practice standards and formatted into user-friendly materials. "

Download (407)

View PDF (931)

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants

World Health Organization (WHO) (2003) C_WHO

The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli... more

Download (1266)

View PDF (1640)

Technical Guide: Sputum Examination for Tuberculosis by Direct Microscopy in Low-Income Countries

International Union Against Tuberculosis and Lung Disease (2000) C1

A technical guide for sputum smear microscopy, initiated by the International Union against Tuberculosis, is designed to be an easy to use reference standard for the collection, storage and transport of sputum specimens and for the examination of sputum smears by direct microscopy. This edition incl... more

Download (163)

View PDF (182)

Mantenimiento de la vigilancia de la gripe y seguimiento del SARS-CoV-2: adaptación del Sistema Mundial de Vigilancia y Respuesta a la Gripe (‎SMVRG)‎ y de los sistemas centinela durante la pandemia

Organización Mundial de la Salud OMS (2021) C_WHO

orientaciones provisionales, 8 de noviembre de 2020 This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e... more

Download (197)

View PDF (161)

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more

Download (261)

View PDF (356)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (348)

View PDF (179)

Infection Prevention and Control Standard Operating Procedures For Cholera Treatment Centres and Units in Malawi (April 2023)

Africa Centres for Disease Control and Prevention Africa CDC; African Union; Government of Malawi; Médecins Sans Frontières; UN Children's Fund UNICEF; World Health Organization WHO (2023) CC

Infection prevention and control (IPC) in a CTC/ CTU IPC are all practical measures taken in the healthcare facility to prevent harm caused by infections to patients, health workers and communities. The main goal of IPC in the cholera response is to • To reduce transmission of health care-as... more

Download (123)

View PDF (156)

Practical manual on tuberculosis laboratory strengthening, 2022 update

World Health Organisation (WHO) (2023) C_WHO

The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la... more

Download (1646)

View PDF (5239)

Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings
recommended

World Health Organization WHO (2009) C2

These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to: • assess prevailing situations and plan for required improvements; • develop and reach essential safety standards as a f... more

Download (199)

View PDF (235)

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended

World Health Organization WHO (2022) C_WHO

This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19. In this edition, new information includes updated mask re... more

Download (198)

View PDF (247)

Global analysis of health care waste in the context of COVID-19

World Health Organization WHO (2022) CC

The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst... more

Download (195)

View PDF (170)

WHO Costing and Budgeting Tool for National Action Plans on Antimicrobial Resistance

World Health Organisation (WHO) (2021) C_WHO

In 2015, to advance the global and national response to antimicrobial resistance (AMR), the World Health Assembly issued resolution WHA68.7 calling for all Member States to develop AMR national action plans that address the five objectives of the World Health Organization Global Action Plan (GAP) by... more

Download (246)

View PDF (265)

Infection prevention and control - Guidance to action tools

World Health Organization WHO (2021) C_WHO

No country can claim to be free from health-care associated infections, therefore, improvement of infection prevention and control (IPC) strategies is essential. WHO recommends the use of multimodal improvement strategies to implement IPC interventions. These include each item of standard and transm... more

Download (132)

View PDF (185)

Joint statement on infant and young child feeding in emergencies - Ethiopia, July 2021

FMOH, NDRMC, UNHCR, WHO, Unicef, WFP (2021) C_WHO

The Federal Ministry of Health of Ethiopia (FMOH), the National Disaster Risk Management Commission (NDRMC) and other government actors together with UN agencies (UNICEF, UNHCR, WHO and WFP) and nutrition development partners call for all parties involved in the response to emergencies in Ethiopia t... more

Download (97)

View PDF (128)

Infection prevention and control health-care facility response for COVID-19
recommended

World Health Organization WHO (2020) C_WHO

A module from the suite of health service capacity assessments in the context of the COVID-19 pandemic, Interim Guidance 20 October 2020. This self-assessment tool is designed for acute health-care facilities (i.e. tertiary and secondary) but can be modified for the use in long-term care facilities... more

Download (139)

View PDF (161)

Interim Guidance on Public Health and Social Measures for COVID-19 Preparedness and Response Operations in Low Capacity and Humanitarian Settings

Inter-Agency Standing Committee IASC (2020) C1

This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co... more

Download (185)

View PDF (216)

WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended

World Health Organization WHO (2020) C_WHO

The aim of this guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing ... more

Download (101)

View PDF (150)

Trainer’s Guide - Section 3: Training Basics

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO

Accessed: 08.03.2020 Facilitating means a lot of things. The table below provides an outline of the topics discussed in this section: - Know Your Audience - Apply Adult Learning Principles - Be Prepared to Train - Manage the Training - Communicate Effectively - Engage the Participants -Use... more

Download (117)

View PDF (163)

Continuing essential sexual, reproductive, maternal, neonatal, child and adolescent health services during the COVID-19 pandemic

World Health Organization (WHO), Regional Office for South-East Asia; UNICEF; UNFPA (2020) CC

Practical considerations It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance... more

Download (154)

View PDF (187)

Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A WHO practical toolkit

World Health Organization WHO (2019) C_WHO

Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”. It was originally applied in the health-care setting as a tool for optimizing antimicrobial use, termed “antimicrobial stewardship” (AMS). Stewardship has since be... more

Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline recommended

Infection prevention and control health-care facility response for COVID-19 recommended

WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities recommended

Water, Sanitation and Hygiene Standards for Schools in Low-cost Settings
recommended

Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
recommended

Infection prevention and control health-care facility response for COVID-19
recommended

WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities
recommended